Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 46 Issue 9, September 2023

Editorial

Top of page ⤴

Article

Top of page ⤴

Comment

Top of page ⤴

Review Article

Top of page ⤴

Article

Top of page ⤴

Review Article

  • Vascular functions in the pathophysiology of hypertension. Vascular dysfunction and elevation of blood pressure are components of a vicious cycle even from their early stages, which including abnormal blood pressure variabilities. This vicious cycle is associated with hypertensive organ damage and also adverse cardiovascular outcomes. Strategies to break this vicious cycle have not yet been fully established.

    • Hirofumi Tomiyama
    Review Article
  • The hypertension trials update summarizes the most important clincal trials on hypertension research in 2022 and early 2023. CTD – chlorthalidone, CV – cardiovascular, HCT – hydrochlorothiazide, SBP – systolic blood pressure, RDN – renal denervation *depicts systolic blood pressure only.

    • Felix Götzinger
    • Michael Kunz
    • Felix Mahfoud
    Review Article
Top of page ⤴

Article

Top of page ⤴

Comment

Top of page ⤴

Correspondence

Top of page ⤴

Search

Quick links